We are thrilled to announce an extension of our existing partnership with the The University of Western Australia to develop an exclusive MDMA-analogue library.
The library, initiated by the highly-regarded research group led by Dr Matthew Piggott, is aimed at identifying MDMA-like compounds that could become treatments for neurological disorders as well as next-generation medicines used in psychotherapy.
“Emyria’s clinical development expertise, funding and international networks have taken our MDMA analogue research to the next level,” said Professor Piggott.
The field of medicinal psychedelic research is gathering steam, with the CSIRO also recently announcing a move into developing new treatments and improving existing ones.
Read more about the UWA agreement here
